For eight years, the DNB Nordic-American Healthcare Conference (formerly the Nordic American Life Science Conference) has been the leading US forum for US-Nordic healthcare investment and growth, bringing together promising Nordic innovation from biopharma, medtech, healthtech, and health services companies to US investors, healthcare partners, colleagues, and friends.
A two-day event
The two-day event includes expert panel discussions addressing challenges across drug development, healthtech, commercialization, and the M&A and public market performance that impact investment returns across geography, sector, and stage, along with presentations by leading, late-stage private and mid- to large-cap public Nordic companies ready for US and global investor and BD collaboration. Attendees will also hear from global public companies with dominant roles in drug development, medical and health technologies, public market dynamics, and the acquisition markets.
Location: Shearman & Sterling Conference Center, 599 Lexington Ave @ 52nd St, New York City
The Nordic-American Healthcare Conference 2023 is a collaboration between DNB//Back Bay, Nasdaq, Business Sweden and Innovation Norway, Medicon Valley Alliance, Business Finland and Shearman & Sterling are valued contributors.
Read more about Nordic-American Healthcare Conference 2023 here!
Featured photo: iStock
